Unknown

Dataset Information

0

Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.


ABSTRACT: A higher levodopa dose is a strong risk factor for levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). However, levodopa dose can change during long-term medication. We explored the relationship between levodopa dose and time to onset of LID using longitudinal multicenter data. Medical records of 150 patients who were diagnosed with de novo PD and treated with levodopa until onset of LID were collected. Levodopa dose were assessed as the dose at 6 months from levodopa initiation and rate of dose increase between 6 months and onset of LID. The groups with earlier LID onset had higher levodopa and levodopa-equivalent dose at the first 6 months of treatment and rapid increase in both levodopa and levodopa-equivalent dose. Multivariable linear regression models revealed that female sex, severe motor symptom at levodopa initiation, and higher rate of increase in both levodopa and levodopa-equivalent dose were significantly associated with early onset of LID. The present results demonstrated that rapid increase in levodopa dose or levodopa-equivalent dose is associated with early onset of LID.

SUBMITTER: Hong JY 

PROVIDER: S-EPMC7444533 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.

Hong Jin Yong JY   Sunwoo Mun Kyung MK   Yoon Jung Han JH   Kang Suk Yun SY   Sohn Young H YH   Lee Phil Hyu PH   Kim Seo Hyun SH  

PloS one 20200820 8


A higher levodopa dose is a strong risk factor for levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). However, levodopa dose can change during long-term medication. We explored the relationship between levodopa dose and time to onset of LID using longitudinal multicenter data. Medical records of 150 patients who were diagnosed with de novo PD and treated with levodopa until onset of LID were collected. Levodopa dose were assessed as the dose at 6 months from levodopa in  ...[more]

Similar Datasets

| S-EPMC6856615 | biostudies-literature
| S-EPMC8594500 | biostudies-literature
| S-EPMC9314442 | biostudies-literature
| S-EPMC8486836 | biostudies-literature
| S-EPMC7034502 | biostudies-literature
| S-EPMC6407061 | biostudies-literature
| S-EPMC7089871 | biostudies-literature
| S-EPMC8281260 | biostudies-literature
| S-EPMC8118664 | biostudies-literature
| S-EPMC8320054 | biostudies-literature